Education
About Us
Working with TipRanks
Follow Us
Medexus Pharmaceuticals Inc (TSE:MDP)
TSX:MDP
RESEARCH TOOLSreports
Total Valuation
Medexus Pharmaceuticals Inc has a market cap or net worth of C$85.48M. The enterprise value is C$130.64M.
Market CapC$85.48M
Enterprise ValueC$130.64M
Share Statistics
Medexus Pharmaceuticals Inc has 32,258,354 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding32,258,354
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Medexus Pharmaceuticals Inc’s return on equity (ROE) is >-0.01 and return on invested capital (ROIC) is -20.71%.
Return on Equity (ROE)>-0.01
Return on Assets (ROA)>-0.01
Return on Invested Capital (ROIC)-20.71%
Return on Capital Employed (ROCE)0.12
Revenue Per Employee1.38M
Profits Per Employee-2.61K
Employee Count82
Asset Turnover0.73
Inventory Turnover1.74
Valuation Ratios
The current PE Ratio of Medexus Pharmaceuticals Inc is -123.67. Medexus Pharmaceuticals Inc’s PEG ratio is 1.07.
PE Ratio-123.67
PS Ratio0.00
PB Ratio0.87
Price to Fair Value0.87
Price to FCF1.43
Price to Operating Cash Flow1.41
PEG Ratio1.07
Income Statement
In the last 12 months, Medexus Pharmaceuticals Inc had revenue of 113.05M and earned -214.00K in profits. Earnings per share was -0.01.
Revenue113.05M
Gross Profit59.51M
Operating Income10.79M
Pretax Income106.00K
Net Income-214.00K
EBITDA19.28M
Earnings Per Share (EPS)-0.01
Cash Flow
In the last 12 months, operating cash flow was 23.36M and capital expenditures -2.89M, giving a free cash flow of 20.47M billion.
Operating Cash Flow23.36M
Free Cash Flow20.47M
Free Cash Flow per Share0.63
Dividends & Yields
Medexus Pharmaceuticals Inc pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.04
52-Week Price Change77.99%
50-Day Moving Average2.54
200-Day Moving Average2.77
Relative Strength Index (RSI)62.55
Average Volume (3m)45.87K
Important Dates
Medexus Pharmaceuticals Inc upcoming earnings date is Jul 1, 2025, TBA Not Confirmed.
Last Earnings DateFeb 5, 2025
Next Earnings DateJul 1, 2025
Ex-Dividend Date―
Financial Position
Medexus Pharmaceuticals Inc as a current ratio of 1.09, with Debt / Equity ratio of 120.58%
Current Ratio1.09
Quick Ratio0.63
Debt to Market Cap1.89
Net Debt to EBITDA2.32
Interest Coverage Ratio0.81
Taxes
In the past 12 months, Medexus Pharmaceuticals Inc has paid 320.00K in taxes.
Income Tax320.00K
Effective Tax Rate3.02
Enterprise Valuation
Medexus Pharmaceuticals Inc EV to EBITDA ratio is 3.69, with an EV/FCF ratio of 3.85.
EV to Sales0.63
EV to EBITDA3.69
EV to Free Cash Flow3.85
EV to Operating Cash Flow3.80
Balance Sheet
Medexus Pharmaceuticals Inc has C$8.44M in cash and marketable securities with $0.00 in debt, giving a net cash position of C$31.47M billion.
Cash & Marketable SecuritiesC$8.44M
Total Debt$0.00
Net CashC$31.47M
Net Cash Per ShareC$0.98
Tangible Book Value Per Share-C$1.98
Margins
Gross margin is 52.45%, with operating margin of 9.55%, and net profit margin of -0.19%.
Gross Margin52.45%
Operating Margin9.55%
Pretax Margin0.09%
Net Profit Margin-0.19%
EBITDA Margin17.05%
EBIT Margin11.91%
Analyst Forecast
The average price target for Medexus Pharmaceuticals Inc is C$8.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price TargetC$8.00
Price Target Upside182.69% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast-3.82%
EPS Growth Forecast-50.36%